Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction

NCT ID: NCT06069232

Last Updated: 2023-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2028-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18
* diagnosed as aortic valve disease

Exclusion Criteria

* aortic valve replacement at baseline
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital, Sun Yat-Sen University

OTHER

Sponsor Role collaborator

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

Sponsor Role collaborator

Affiliated Hospital of Guangdong Medical University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Shantou University Medical College

OTHER

Sponsor Role collaborator

Eighth Affiliated Hospital, Sun Yat-sen University

OTHER

Sponsor Role collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

Sponsor Role collaborator

Jieyang People's Hospital

OTHER

Sponsor Role collaborator

Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiao-dong Zhuang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

xiaodong zhuang, PhD

Role: PRINCIPAL_INVESTIGATOR

First Affiliated Hospital, Sun Yat-Sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Affiliated Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, China

Site Status RECRUITING

Third Affiliated Hospital, Sun Yat-Sun University

Guangzhou, Guangdong, China

Site Status RECRUITING

Jieyang People's Hospital

Jieyang, Guangdong, China

Site Status RECRUITING

Second Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China

Site Status RECRUITING

Eighth Affiliated Hospital, Sun Yat-Sen University

Shenzhen, Guangdong, China

Site Status RECRUITING

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, China

Site Status RECRUITING

Zhongshan People's Hospital

Zhongshan, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

xiaodong zhuang, PhD

Role: CONTACT

+86 13760755035

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

xiaodong zhuang, PhD

Role: primary

+86 13760755035

zhuoshan Huang, PhD

Role: primary

+86 13728059476

Mingwei Xu, PhD

Role: primary

13828186368

Jilin Li, PhD

Role: primary

+86 13592852807

jianwen liang, PhD

Role: primary

+86 13688847419

Jianying Chen, PhD

Role: primary

+86 13828223032

li Feng, PhD

Role: primary

+86 13902593410

References

Explore related publications, articles, or registry entries linked to this study.

Guo Z, Xiong Z, Zhang W, Chen G, Xie M, Zhou Z, Zhang S, Liu M, Li J, Liao X, Zhuang X. Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. Cardiovasc Diabetol. 2025 Oct 11;24(1):393. doi: 10.1186/s12933-025-02906-2.

Reference Type DERIVED
PMID: 41076530 (View on PubMed)

Li B, Zhang S, Xu C, Huang M, Xiong Z, Hui Z, Liao X, Li J, Chen J, Zhuang X. Association Between the Malnutrition Status and All-Cause Mortality in Patients With Moderate and Severe Aortic Stenosis: A Prospective Cohort Study. J Am Heart Assoc. 2025 Feb 4;14(3):e037086. doi: 10.1161/JAHA.124.037086. Epub 2025 Feb 3.

Reference Type DERIVED
PMID: 39895526 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARISTOTLE Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

China Valve Registry Study-1
NCT02623907 UNKNOWN
Clinical Trial in China
NCT05580952 UNKNOWN NA